Evidence map›Paper›PMID 39905141›Full record

ArticleScientific reports2025

Exploiting question-answer framework with multi-GRU to detect adverse drug reaction on social media.

Jiao-Huang Luo, Ai-Hua Yang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jiao-Huang LuoMinnan University of Science and Technology, Quanzhou, 362000, China. 1104674880@qq.com.
Ai-Hua YangSchool of Information and Media, Zhangzhou Vocational College of Science and Technology, Zhangzhou, 363202, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse Drug Reactions (ADRs) stand out as a pressing challenge in public health and a critical aspect of drug discovery. The dilemma arises from the inherent impossibility of conducting a comprehensive evaluation of a drug before its market release, constrained by the limitations in scale and duration of clinical trials. Therefore, the post-marketing detection of ADRs in a timely and accurate manner becomes imperative. Adding to the complexity, a multitude of tweets harbor concealed information about adverse drug reactions, creating difficulties due to their concise, sporadic, and noisy content. To solve the problem, we regard ADR detection as a question-answer problem and introduces an innovative neural network framework with multiple GRU layers designed for extracting ADR-related information from tweets. The Von Mises-Fisher distribution is applied to derive keyword vectors through tweet sampling. An attention mechanism is employed to enhance the interaction between these keyword vectors and the word sequences within tweets. The credibility of word sequences is systematically evaluated based on the reliability of answer factors. To address concerns related to background information and training speed, we propose a quality assurance mechanism utilizing a GRU network due to its straightforward structure and efficient training capabilities. As a result of the training process, word sequences are mapped to a low-latitude vector space, generating corresponding answers. Experimental results obtained from two Twitter ADR datasets affirm that our Question-Answer Mechanism, leveraging multi-GRU architecture, significantly improves the accuracy of ADR detection in tweets. Our method achieved F1-scores of 81.3% and 73.3% on the two datasets, respectively, while consistently maintaining a higher recall.

Indexed as

Drug-Related Side Effects and Adverse ReactionsSocial MediaAlgorithmsHumansNeural Networks, Computer

Identifiers

PMID39905141
PMCPMC11794948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.